TreeFrog Therapeutics logo

TreeFrog Therapeutics

ID: 7646722

TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable.

3

Funding Rounds

$157.3m

Money raised

Overview

TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company TreeFrog Therapeutics has raised a total of $157.3m in funding over 3 rounds.

Key Insights:

  • TreeFrog Therapeutics Series B round, September 2021: $75m
  • TreeFrog Therapeutics September 2021 Funding Round: $75m
  • TreeFrog Therapeutics May 2019 Series A Funding Round: $7.3m